Loading clinical trials...
Loading clinical trials...
Reducing Non-Alcoholic Steatohepatitis Study
Conditions
Interventions
Empagliflozin 10 miligrams (mg)
Locations
1
Czechia
Central Military Hospital
Prague, Czechia
Start Date
April 1, 2024
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2027
Last Updated
July 25, 2024
NCT06513026
NCT00345930
NCT07112339
NCT06613698
NCT06329375
NCT06945406
Lead Sponsor
Military University Hospital, Prague
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions